Novel antibacterial agents are being developed, with 57 traditional antibacterial agents and 40 nontraditional agents listed in the clinical antibacterial pipeline in 2023. However, the current pipeline is insufficient to keep up with the emergence and spread of AMR journals.plos.org/plosbiology/...
Global antimicrobial resistance—The ostrich’s head is in the sandAntimicrobial resistance (AMR) is a growing problem, ignored at our peril. This Perspective outlines the technical difficulties and challenges raised by the lack of market incentives for new diagnosti...journals.plos.org
